This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2011 Apr 1;203(7):894-7.

doi: 10.1093/infdis/jiq150.

Hide and seek... Can we eradicate HIV by treatment intensification?

Julian Schulze zur Wiesch, Jan van Lunzen

PMID: 21402541
DOI: 10.1093/infdis/jiq150

Editorial

Hide and seek... Can we eradicate HIV by treatment intensification?

Julian Schulze zur Wiesch et al. J Infect Dis. 2011.

. 2011 Apr 1;203(7):894-7.

doi: 10.1093/infdis/jiq150.

Authors

Julian Schulze zur Wiesch, Jan van Lunzen

PMID: 21402541
DOI: 10.1093/infdis/jiq150

No abstract available

PubMed Disclaimer

Comment on

A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response.
Hatano H, Hayes TL, Dahl V, Sinclair E, Lee TH, Hoh R, Lampiris H, Hunt PW, Palmer S, McCune JM, Martin JN, Busch MP, Shacklett BL, Deeks SG. Hatano H, et al. J Infect Dis. 2011 Apr 1;203(7):960-8. doi: 10.1093/infdis/jiq138. J Infect Dis. 2011. PMID: 21402547 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information